HFA Premium Access

Cardiovascular diseases and type 2 diabetes mellitus: high heart failure risk and low rate contraindications to SGLT2i

Congress Presentation

About the speaker

Assistant Professor Vadim Medovchshikov

West Kazakhstan Marat Ospanov Medical University, Aktobe (Kazakhstan)
2 followers

5 more presentations in this session

Eligibility for semaglutide according to the SELECT trial in a Portuguese cohort of acute coronary syndrome

Speaker: Doctor V. Lopes (Coimbra, PT)

Thumbnail

Evaluation of the triglyceride-glucose index as a predictor of metabolic syndrome in elderly population. EVITGA-60 study

Speaker: Doctor L. Calvo Betancourt (Bogota, CO)

Thumbnail

Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study

Speaker: Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Thumbnail

CTO recanalization in type 2 diabetic patients: procedural and long-term prognosis

Speaker: Doctor A. Silva (Coimbra, PT)

Thumbnail

Impact of dapagliflozin on exercise-induced hypertrophy: insights from a rodent model of athlete's heart

Speaker: Doctor A. Olah (Budapest, HU)

Thumbnail

Access the full session

Risk factors and prevention

Speakers: Assistant Professor V. Medovchshikov, Doctor V. Lopes, Doctor L. Calvo Betancourt, Doctor R. Gonzalez-Manzanares, Doctor A. Silva...
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations